Astrana Health Key Fundamental Indicators

ASTH Stock   18.78  0.62  3.41%   
As of the 15th of February 2026, Astrana Health shows the Mean Deviation of 3.06, standard deviation of 4.57, and Risk Adjusted Performance of (0.02). Astrana Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Astrana Health Total Revenue

2.46 Billion

Astrana Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Astrana Health's valuation are provided below:
Gross Profit
297 M
Profit Margin
0.0033
Market Capitalization
941.9 M
Enterprise Value Revenue
0.5406
Revenue
2.9 B
We have found one hundred twenty available fundamental signals for Astrana Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Astrana Health prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 1 B. Enterprise Value is estimated to decrease to about 1.1 B This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
As of now, Astrana Health's EBIT is increasing as compared to previous years. The Astrana Health's current Total Operating Expenses is estimated to increase to about 219.8 M, while Total Other Income Expense Net is forecasted to increase to (7.3 M).
  
Build AI portfolio with Astrana Stock

Astrana Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 B1.6 B584.1 M
Slightly volatile
Other Current Liabilities389.4 M370.9 M103.9 M
Slightly volatile
Total Current Liabilities441.5 M420.4 M126 M
Slightly volatile
Accounts Payable18.3 M17.4 M7.8 M
Slightly volatile
Cash348.3 M331.7 M137.6 M
Slightly volatile
Cash And Short Term Investments351.2 M334.5 M152.7 M
Slightly volatile
Common Stock Total Equity30 K54 K33.3 K
Slightly volatile
Common Stock Shares Outstanding58.2 M55.5 M30.8 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1.6 B584.1 M
Slightly volatile
Non Current Liabilities Total573.7 M546.4 M178.1 M
Slightly volatile
Other Stockholder Equity514.9 M490.3 M194.6 M
Slightly volatile
Total LiabilitiesB966.8 M304.1 M
Slightly volatile
Total Current Assets771 M734.3 M263.1 M
Slightly volatile
Common Stock34.2 K55.2 K36.4 K
Slightly volatile
Short and Long Term Debt Total569.7 M542.6 M170.6 M
Slightly volatile
Short Term Debt18.4 M17.6 M7.3 M
Slightly volatile
Property Plant And Equipment Net56.6 M53.9 M29.6 M
Slightly volatile
Non Current Assets Total865.1 M823.9 M321 M
Slightly volatile
Non Currrent Assets Other76.3 M72.7 M15.8 M
Slightly volatile
Net Receivables392.2 M373.5 M100.6 M
Slightly volatile
Other Current Assets27.6 M26.3 M9.8 M
Slightly volatile
Property Plant And Equipment Gross86.4 M82.3 M35.8 M
Slightly volatile
Current Deferred Revenue1.8 M1.8 M3.5 M
Pretty Stable
Long Term Debt513.5 M489.1 M151 M
Slightly volatile
Good Will506.2 M482.1 M180 M
Slightly volatile
Long Term Debt Total245.6 M233.9 M103.4 M
Slightly volatile
Capital Surpluse434.8 M414.1 M181 M
Slightly volatile
Intangible Assets142.7 M135.9 M59.5 M
Slightly volatile
Property Plant Equipment155.7 M148.3 M50.8 M
Slightly volatile
Other Liabilities28.2 M21 M26.8 M
Very volatile
Short and Long Term Debt6.2 M10.8 M6.2 M
Slightly volatile
Long Term Investments39.7 M55.4 M30.6 M
Slightly volatile
Non Current Liabilities Other14.7 M12.6 M13.1 M
Slightly volatile
Warrants11.7 M12.3 M118 M
Slightly volatile
Capital Lease Obligations21.7 M42.7 M13.4 M
Slightly volatile
Net Invested Capital659.9 M1.3 B466.9 M
Slightly volatile
Net Working Capital229.6 M313.8 M144.4 M
Slightly volatile
Capital Stock47.1 K55.2 K39.9 K
Slightly volatile

Astrana Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.3 B2.2 B668.9 M
Slightly volatile
Selling General Administrative186.1 M177.2 M55.8 M
Slightly volatile
Total Revenue2.5 B2.3 B711.9 M
Slightly volatile
Cost Of Revenue2.1 BB602.8 M
Slightly volatile
Depreciation And Amortization33.7 M32.1 M13.1 M
Slightly volatile
Gross Profit327.7 M312.1 M109.1 M
Slightly volatile
Interest Income17.5 M16.7 M4.8 M
Slightly volatile
Non Recurring539.2 K567.6 K1.9 M
Slightly volatile
Reconciled Depreciation21.5 M32.1 M20.2 M
Slightly volatile
Extraordinary Items7.8 M8.7 M9.5 M
Slightly volatile

Astrana Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow355.2 M338.3 M121.5 M
Slightly volatile
End Period Cash Flow349.1 M332.5 M137.4 M
Slightly volatile
Depreciation33.7 M32.1 M13.1 M
Slightly volatile
Stock Based Compensation41.7 M39.7 M10.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.180.670.9907
Slightly volatile
Dividend Yield0.00290.00310.0235
Very volatile
PTB Ratio2.451.92.0986
Slightly volatile
Days Sales Outstanding35.5852.4439.6699
Slightly volatile
Book Value Per Share11.7812.45.8 M
Slightly volatile
Stock Based Compensation To Revenue0.0090.01530.0069
Slightly volatile
Capex To Depreciation0.470.260.5827
Very volatile
PB Ratio2.451.92.0986
Slightly volatile
Payables Turnover58.710554.0505
Slightly volatile
Sales General And Administrative To Revenue0.05620.06820.0713
Slightly volatile
Capex To Revenue0.00340.00360.0077
Pretty Stable
Cash Per Share6.667.016.3 M
Slightly volatile
Days Payables Outstanding3.433.6113.9718
Slightly volatile
Income Quality1.010.940.962
Slightly volatile
EV To Operating Cash Flow20.4229.0918.4312
Slightly volatile
EV To Free Cash Flow25.2434.3822.0592
Slightly volatile
Intangibles To Total Assets0.290.360.2742
Slightly volatile
Current Ratio1.941.572.1068
Slightly volatile
Receivables Turnover10.17.210.1675
Slightly volatile
Graham Number11.215.713.3823
Slightly volatile
Shareholders Equity Per Share16.3317.193.9 M
Slightly volatile
Debt To Equity0.380.60.3242
Slightly volatile
Capex Per Share0.180.19177.5 K
Slightly volatile
Average Receivables46.8 M70.4 M55 M
Slightly volatile
Revenue Per Share46.6149.0629.8 M
Slightly volatile
Interest Debt Per Share11.5712.18495 K
Slightly volatile
Debt To Assets0.170.310.1425
Slightly volatile
Enterprise Value Over EBITDA11.0810.79.4024
Slightly volatile
Operating Cycle35.5852.4439.6699
Slightly volatile
Price Book Value Ratio2.451.92.0986
Slightly volatile
Days Of Payables Outstanding3.433.6113.9718
Slightly volatile
Ebt Per Ebit1.131.041.1218
Slightly volatile
Effective Tax Rate0.30.340.2405
Slightly volatile
Company Equity Multiplier2.772.192.7977
Slightly volatile
Long Term Debt To Capitalization0.260.340.1997
Slightly volatile
Total Debt To Capitalization0.220.360.1927
Slightly volatile
Debt Equity Ratio0.380.60.3242
Slightly volatile
Quick Ratio1.941.572.1068
Slightly volatile
Cash Ratio1.120.711.2793
Very volatile
Days Of Sales Outstanding35.5852.4439.6699
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.970.9668
Slightly volatile
Price To Book Ratio2.451.92.0986
Slightly volatile
Fixed Asset Turnover27.5849.9129.7347
Pretty Stable
Enterprise Value Multiple11.0810.79.4024
Slightly volatile
Debt Ratio0.170.310.1425
Slightly volatile
Price Sales Ratio1.180.670.9907
Slightly volatile
Asset Turnover1.251.731.485
Slightly volatile
Gross Profit Margin0.20.150.189
Slightly volatile
Price Fair Value2.451.92.0986
Slightly volatile

Astrana Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market CapB1.4 B793.6 M
Slightly volatile

Astrana Fundamental Market Drivers

Forward Price Earnings23.0415
Cash And Short Term Investments290.8 M

Astrana Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Astrana Health is extremely important. It helps to project a fair market value of Astrana Stock properly, considering its historical fundamentals such as Current Valuation. Since Astrana Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Astrana Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Astrana Health's interrelated accounts and indicators.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.19
Revenue Per Share
59.463
Quarterly Revenue Growth
0.997
Return On Assets
0.0288
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Astrana Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Astrana Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Astrana Health.
0.00
11/17/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/15/2026
0.00
If you would invest  0.00  in Astrana Health on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Astrana Health or generate 0.0% return on investment in Astrana Health over 90 days. Astrana Health is related to or competes with Select Medical, Mednax, National HealthCare, Aveanna Healthcare, Acadia Healthcare, US Physicalrapy, and MannKind Corp. Astrana Health is entity of United States More

Astrana Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Astrana Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Astrana Health upside and downside potential and time the market with a certain degree of confidence.

Astrana Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Astrana Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Astrana Health's standard deviation. In reality, there are many statistical measures that can use Astrana Health historical prices to predict the future Astrana Health's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.2218.7723.32
Details
Intrinsic
Valuation
LowRealHigh
18.1622.7127.26
Details
12 Analysts
Consensus
LowTargetHigh
32.4635.6739.59
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.530.530.53
Details

Astrana Health February 15, 2026 Technical Indicators

Astrana Health Backtested Returns

Astrana Health secures Sharpe Ratio (or Efficiency) of -0.0163, which signifies that the company had a -0.0163 % return per unit of risk over the last 3 months. Astrana Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Astrana Health's Mean Deviation of 3.06, standard deviation of 4.57, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.53, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astrana Health will likely underperform. At this point, Astrana Health has a negative expected return of -0.0742%. Please make sure to confirm Astrana Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Astrana Health performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.69  

Very good reverse predictability

Astrana Health has very good reverse predictability. Overlapping area represents the amount of predictability between Astrana Health time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Astrana Health price movement. The serial correlation of -0.69 indicates that around 69.0% of current Astrana Health price fluctuation can be explain by its past prices.
Correlation Coefficient-0.69
Spearman Rank Test-0.59
Residual Average0.0
Price Variance12.78
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Astrana Health has a Current Valuation of 1.57 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is notably lower than that of the firm.

Astrana Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Astrana Health's current stock value. Our valuation model uses many indicators to compare Astrana Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astrana Health competition to find correlations between indicators driving Astrana Health's intrinsic value. More Info.
Astrana Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  1.57  of Return On Asset per Return On Equity. As of now, Astrana Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astrana Health's earnings, one of the primary drivers of an investment's value.

Astrana Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.
Astrana Health is currently under evaluation in current valuation category among its peers.

Astrana Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of Astrana Health from analyzing Astrana Health's financial statements. These drivers represent accounts that assess Astrana Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Astrana Health's important valuation drivers and their relationship over time.
202120222023202420252026 (projected)
Market Cap3.2B1.3B1.8B1.5B1.4B1.0B
Enterprise Value3.2B1.3B1.8B1.7B1.5B1.1B

Astrana Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Astrana Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Astrana Health's managers, analysts, and investors.
Environmental
Governance
Social

Astrana Fundamentals

About Astrana Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 M1.8 M
Total Revenue2.3 B2.5 B
Cost Of RevenueB2.1 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.07  0.06 
Revenue Per Share 49.06  46.61 
Ebit Per Revenue 0.04  0.05 

Currently Active Assets on Macroaxis

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
Check out
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.19
Revenue Per Share
59.463
Quarterly Revenue Growth
0.997
Return On Assets
0.0288
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.